vs
Side-by-side financial comparison of ENERGIZER HOLDINGS, INC. (ENR) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
ENERGIZER HOLDINGS, INC. is the larger business by last-quarter revenue ($778.9M vs $622.0M, roughly 1.3× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs -0.4%, a 34.9% gap on every dollar of revenue. On growth, ENERGIZER HOLDINGS, INC. posted the faster year-over-year revenue change (6.5% vs 4.8%). Over the past eight quarters, ENERGIZER HOLDINGS, INC.'s revenue compounded faster (8.4% CAGR vs 4.6%).
Energizer Holdings, Inc. is an American manufacturer and one of the world's largest manufacturers of batteries, headquartered in Clayton, Missouri. It produces batteries under the Energizer, Ray-O-Vac, Varta, and Eveready brand names and formerly owned several personal care businesses until it separated that side of the business into a new company called Edgewell Personal Care in 2015.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
ENR vs RPRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $778.9M | $622.0M |
| Net Profit | $-3.4M | $214.2M |
| Gross Margin | 32.9% | — |
| Operating Margin | -0.6% | 62.4% |
| Net Margin | -0.4% | 34.4% |
| Revenue YoY | 6.5% | 4.8% |
| Net Profit YoY | -115.2% | 2.9% |
| EPS (diluted) | — | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $778.9M | $622.0M | ||
| Q3 25 | $832.8M | $609.3M | ||
| Q2 25 | $725.3M | $578.7M | ||
| Q1 25 | $662.9M | $568.2M | ||
| Q4 24 | $731.7M | $593.6M | ||
| Q3 24 | $805.7M | $564.7M | ||
| Q2 24 | $701.4M | $537.3M | ||
| Q1 24 | $663.3M | $568.0M |
| Q4 25 | $-3.4M | $214.2M | ||
| Q3 25 | $34.9M | $288.2M | ||
| Q2 25 | $153.5M | $30.2M | ||
| Q1 25 | $28.3M | $238.3M | ||
| Q4 24 | $22.3M | $208.2M | ||
| Q3 24 | $47.6M | $544.0M | ||
| Q2 24 | $-43.8M | $102.0M | ||
| Q1 24 | $32.4M | $4.8M |
| Q4 25 | 32.9% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 39.1% | — | ||
| Q4 24 | 36.8% | — | ||
| Q3 24 | 38.1% | — | ||
| Q2 24 | 39.5% | — | ||
| Q1 24 | 38.2% | — |
| Q4 25 | -0.6% | 62.4% | ||
| Q3 25 | 6.4% | 70.1% | ||
| Q2 25 | 22.6% | 36.3% | ||
| Q1 25 | 5.5% | 94.0% | ||
| Q4 24 | 4.1% | 60.9% | ||
| Q3 24 | 7.4% | — | ||
| Q2 24 | -8.2% | 50.2% | ||
| Q1 24 | 6.4% | -13.0% |
| Q4 25 | -0.4% | 34.4% | ||
| Q3 25 | 4.2% | 47.3% | ||
| Q2 25 | 21.2% | 5.2% | ||
| Q1 25 | 4.3% | 41.9% | ||
| Q4 24 | 3.0% | 35.1% | ||
| Q3 24 | 5.9% | 96.3% | ||
| Q2 24 | -6.2% | 19.0% | ||
| Q1 24 | 4.9% | 0.8% |
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $214.8M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $141.3M | $9.7B |
| Total Assets | $4.4B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $214.8M | $618.7M | ||
| Q3 25 | $236.2M | $938.9M | ||
| Q2 25 | $171.1M | $631.9M | ||
| Q1 25 | $139.3M | $1.1B | ||
| Q4 24 | $195.9M | $929.0M | ||
| Q3 24 | $216.9M | $950.1M | ||
| Q2 24 | $146.7M | $1.8B | ||
| Q1 24 | $158.1M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | $3.4B | $8.9B | ||
| Q2 25 | $3.2B | $8.0B | ||
| Q1 25 | $3.2B | $7.6B | ||
| Q4 24 | $3.1B | $7.6B | ||
| Q3 24 | $3.2B | $7.6B | ||
| Q2 24 | $3.2B | $7.6B | ||
| Q1 24 | $3.2B | $6.1B |
| Q4 25 | $141.3M | $9.7B | ||
| Q3 25 | $169.9M | $9.6B | ||
| Q2 25 | $183.2M | $9.5B | ||
| Q1 25 | $133.9M | $9.8B | ||
| Q4 24 | $140.6M | $10.3B | ||
| Q3 24 | $135.8M | $10.3B | ||
| Q2 24 | $123.4M | $9.8B | ||
| Q1 24 | $191.3M | $9.9B |
| Q4 25 | $4.4B | $19.6B | ||
| Q3 25 | $4.6B | $19.3B | ||
| Q2 25 | $4.5B | $18.3B | ||
| Q1 25 | $4.2B | $17.6B | ||
| Q4 24 | $4.2B | $18.2B | ||
| Q3 24 | $4.3B | $18.0B | ||
| Q2 24 | $4.2B | $17.7B | ||
| Q1 24 | $4.3B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | 20.28× | 0.93× | ||
| Q2 25 | 17.57× | 0.84× | ||
| Q1 25 | 23.56× | 0.78× | ||
| Q4 24 | 22.17× | 0.74× | ||
| Q3 24 | 23.51× | 0.74× | ||
| Q2 24 | 26.04× | 0.78× | ||
| Q1 24 | 16.86× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $149.5M | $827.1M |
| Free Cash FlowOCF − Capex | $124.2M | — |
| FCF MarginFCF / Revenue | 15.9% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $145.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $149.5M | $827.1M | ||
| Q3 25 | $61.5M | $702.6M | ||
| Q2 25 | $21.4M | $364.0M | ||
| Q1 25 | $-12.8M | $596.1M | ||
| Q4 24 | $77.0M | $742.5M | ||
| Q3 24 | $168.9M | $703.6M | ||
| Q2 24 | $45.8M | $658.2M | ||
| Q1 24 | $36.8M | $664.6M |
| Q4 25 | $124.2M | — | ||
| Q3 25 | $46.7M | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $-33.8M | — | ||
| Q4 24 | $42.4M | — | ||
| Q3 24 | $141.5M | — | ||
| Q2 24 | $27.3M | — | ||
| Q1 24 | $10.3M | — |
| Q4 25 | 15.9% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | -5.1% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 4.0% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | 1.76× | 2.44× | ||
| Q2 25 | 0.14× | 12.06× | ||
| Q1 25 | -0.45× | 2.50× | ||
| Q4 24 | 3.45× | 3.57× | ||
| Q3 24 | 3.55× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 1.14× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENR
| Alkaline Batteries | $666.5M | 86% |
| Auto Care | $93.7M | 12% |
| Lights | $18.7M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
